Cell Signaling in Cancer: Communicating Recent Advances

Listicle

Published: November 3, 2021

Masha Savelieff, PhD

Cell Signaling in Cancer: Communicating Recent Advances content piece image

Disruptions to carefully orchestrated cell signaling pathways can lead to pathological states. In cancer, genetic mutations or epigenetic alterations to genes regulating signaling pathways can promote malignant transformation by triggering various pathological mechanisms. These mechanisms circumvent the cell’s normal checks and balances.

Download this listicle to learn how aberrant cell signaling can impact:

Proliferation/metabolism
Cell cycle/DNA repair/apoptosis
Angiogenesis

Meet the Author

Masha Savelieff, PhD

Masha Savelieff holds a PhD in chemistry from the University of Illinois. She completed postdoctoral training in Alzheimer’s disease, cancer research and metabolic disease at the University of Michigan.